116 related articles for article (PubMed ID: 12397130)
21. Complication rates of ablation therapies for hepatocellular carcinoma: a difficult comparison with an easy solution.
Arienti V; Pretolani S
Gut; 2006 Aug; 55(8):1211-2. PubMed ID: 16849356
[No Abstract] [Full Text] [Related]
22. Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection.
Ohnishi K; Yoshioka H; Ito S; Fujiwara K
Hepatology; 1996 Dec; 24(6):1379-85. PubMed ID: 8938165
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
24. Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium-enhanced MR imaging follow-up.
Sironi S; De Cobelli F; Livraghi T; Villa G; Zanello A; Taccagni G; DelMaschio A
Radiology; 1994 Aug; 192(2):407-12. PubMed ID: 8029405
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection.
Lencioni R; Caramella D; Bartolozzi C
Radiology; 1995 Jan; 194(1):113-8. PubMed ID: 7997536
[TBL] [Abstract][Full Text] [Related]
26. Single-session percutaneous ethanol ablation of early-stage hepatocellular carcinoma with a multipronged injection needle: results of a pilot clinical study.
Lencioni R; Crocetti L; Cioni D; Pina CD; Oliveri F; De Simone P; Brunetto M; Filipponi F
J Vasc Interv Radiol; 2010 Oct; 21(10):1533-8. PubMed ID: 20817558
[TBL] [Abstract][Full Text] [Related]
27. Enhanced MR imaging of the liver after ethanol treatment of hepatocellular carcinoma: evaluation of areas of hyperperfusion adjacent to the tumor.
Ito K; Honjo K; Fujita T; Awaya H; Matsumoto T; Matsunaga N
AJR Am J Roentgenol; 1995 Jun; 164(6):1413-7. PubMed ID: 7754884
[TBL] [Abstract][Full Text] [Related]
28. Power Doppler ultrasonography with time-signal intensity curves in monitoring hepatocellular carcinoma and liver metastases after intralesional therapy.
Farina R; Pennisi F; Mazzone G; Pennisi M; Riva G; Foti PV; Puglisi C; Ettorre GC
Radiol Med; 2009 Feb; 114(1):32-41. PubMed ID: 18820993
[TBL] [Abstract][Full Text] [Related]
29. Small hepatocellular carcinoma: MR follow-up of treatment with percutaneous ethanol injection.
Sironi S; Livraghi T; Angeli E; Vanzulli A; Villa G; Colombo E; Taccagni G; DelMaschio A
Radiology; 1993 Apr; 187(1):119-23. PubMed ID: 8383864
[TBL] [Abstract][Full Text] [Related]
30. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
31. Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection.
Huo TI; Huang YH; Wu JC; Lee PC; Chang FY; Lee SD
Scand J Gastroenterol; 2004 Feb; 39(2):168-73. PubMed ID: 15000280
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous ablation of VX2 carcinoma-induced liver tumors with use of ethanol versus acetic acid: pilot study in a rabbit model.
Shah SS; Jacobs DL; Krasinkas AM; Furth EE; Itkin M; Clark TW
J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 1):63-7. PubMed ID: 14709691
[TBL] [Abstract][Full Text] [Related]
33. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings.
Granata V; Fusco R; Catalano O; Piccirillo M; De Bellis M; Izzo F; Petrillo A
AJR Am J Roentgenol; 2015 May; 204(5):1000-7. PubMed ID: 25905934
[TBL] [Abstract][Full Text] [Related]
35. Destructive effect of percutaneous hydrochloric acid injection therapy for liver cancer--a preliminary experimental and clinical study.
Weijian F; Zan L; Suhong H; Hongmei Z; Lei Z; Yanjie Z; Yi C; Ni J
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1852-6. PubMed ID: 17212126
[TBL] [Abstract][Full Text] [Related]
36. Local ablation therapy for hepatocellular carcinoma. From ethanol injection to radiofrequency ablation.
Shiina S; Tateishi R; Yoshida H; Kanai F; Omata M
Saudi Med J; 2007 Jun; 28(6):831-7. PubMed ID: 17530094
[TBL] [Abstract][Full Text] [Related]
37. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.
Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous ablative therapies for small hepatocellular carcinoma: radio-frequency or percutaneous ethanol injection?
Caturelli E
Radiology; 2000 Jul; 216(1):304-6. PubMed ID: 10887266
[No Abstract] [Full Text] [Related]
39. Contrast-enhanced MR imaging of hepatic lesions treated with percutaneous ethanol ablation therapy.
Nagel HS; Bernardino ME
Radiology; 1993 Oct; 189(1):265-70. PubMed ID: 7690490
[TBL] [Abstract][Full Text] [Related]
40. Transcutaneous treatments of hepatocellular carcinoma in patients with cirrhosis: present status and future developments.
Beaugrand M; Seror O
Curr Pharm Des; 2007; 13(32):3274-8. PubMed ID: 18045178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
